Impact of the Duration of Diabetes Mellitus on the Outcome of Metastatic Pancreatic Cancer Treated with Gemcitabine: A Retrospective Study

OBJECTIVE: To assess the impact of the duration of diabetes mellitus (DM) on the outcomes of pancreatic cancer patients undergoing chemotherapy. METHODS: We reviewed the medical records of patients with metastatic pancreatic cancer who received gemcitabine monotherapy as the standard therapy before...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Intern Med
Autors principals: Iizumi, Sakura, Kuchiba, Aya, Okusaka, Takuji, Ikeda, Masafumi, Sakamoto, Yasunari, Kondo, Shunsuke, Morizane, Chigusa, Ueno, Hideki, Osame, Keiichiro, Mitsunaga, Shuichi, Ohno, Izumi, Imaoka, Hiroshi, Hashimoto, Yusuke, Takahashi, Hideaki, Sasaki, Mitsuhito, Ohashi, Ken
Format: Artigo
Idioma:Inglês
Publicat: The Japanese Society of Internal Medicine 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6761348/
https://ncbi.nlm.nih.gov/pubmed/31178491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.2539-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars